This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Philip Jonas Sassene
Introduction
Philip Jonas Sassene is an accomplished inventor based in Copenhagen V, US. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid compositions that incorporate GLP-1 agonists. His work is vital in advancing treatments for various health conditions.
Latest Patents
Philip holds a patent for "Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid." This innovative formulation showcases his expertise in creating effective pharmaceutical compositions that can enhance therapeutic outcomes.
Career Highlights
Philip is currently employed at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. His role at Novo Nordisk allows him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Philip has collaborated with talented professionals, including Simon Bjerregaard and Ulrik Lytt Rahbek. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Philip Jonas Sassene's contributions to the field of pharmaceuticals through his patent and work at Novo Nordisk A/S highlight his dedication to improving healthcare solutions. His innovative spirit and collaborative efforts continue to make a positive impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile